April 14, 2021, 02.22 PM

Also readIndonesias Covid-19 Task Force Urges Calm As Sinovac Vaccine Expires Soon

The overall efficacy rate for the vaccine was slightly above 50 percent in the trial.
China has developed four domestic vaccines approved for public use and a fifth for smaller-scale emergency use.

An official said on Saturday the country will likely produce three billion doses by the end of the year.

No detailed efficacy data has been released on vaccines made by China's Sinopharm.
It has said two vaccines developed by its units are 79.4 percent and 72.5 percent effective, based on interim results.

Both vaccine makers have presented data on their Covid-19 vaccines indicating levels of efficacy in line with those required by WHO.

China has shipped millions of its vaccines abroad and officials and state media have fiercely defended the shots while calling into question the safety and logistics capabilities of other vaccines.

Gao also rejected claims by some media reports that said Chinese Covid-19 vaccines have a low protection rate, telling Global Times that it was "a complete misunderstanding."

Reuters

Dapatkan update berita pilihan dan breaking news setiap hari dari Kompas.com. Mari bergabung di Grup Telegram "Kompas.com News Update", caranya klik link https://t.me/kompascomupdate, kemudian join. Anda harus install aplikasi Telegram terlebih dulu di ponsel.

Page:
Source ABC


Latest Video Video Lainnya >

Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Report
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

News
November 24, 2022, 05.14 PM

Malaysia: Opposition Leader Anwar Ibrahim Named PM

News
November 18, 2022, 10.31 PM

Indonesia Reports over 6,600 Daily Covid-19 Cases

News
November 18, 2022, 09.57 PM

6.9-Magnitude Quake Strikes Off Western Indonesia

Business
November 17, 2022, 05.34 PM

Indonesia, China Renew Economic and Trade Expansion Pact

Close Ads